OP
CADX

Omni Partners’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Omni Partners’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-250,000
Closed -$3.5M – 10
2014
Q1 		$3.5M Buy
+250,000
New +$3.09M 5.2% 4

Omni Partners's CADX Position: Q2 2014 in Review

Omni Partners sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q2 2014, closing a stake of 250,000 shares — an estimated $3.5M sold.

Omni Partners first reported a position in CADX in Q1 2014 and held it in 1 quarter. The position peaked at $3.5M in Q1 2014. 0 funds tracked by Wall St. Rank hold CADX as of Q2 2014.

  • Omni Partners reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q2 2014 after selling out during the quarter.
  • Omni Partners sold 250,000 CADENCE PHARMACEUTICALS, INC COM STK shares in Q2 2014, an estimated $3.5M.
  • Omni Partners first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q1 2014 and held it in 1 quarter.
  • Omni Partners's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $3.5M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q2 2014.

Based on Omni Partners's 13F filing for Q2 2014, filed 12 Aug 2014.